Tp53inp2-Dependent Activation of Muscle Autophagy Ameliorates Sarcopenia and Promotes Healthy Aging Publisher Pubmed



Sebastian D^{1, 2, 3} ; Beltra M^{2, 3, 4} ; Irazoki A^{2, 3, 4} ; Sala D^{2, 3, 4} ; Aparicio P⁵ ; Aris C⁶ ; Alibakhshi E^{7, 8, 9} ; Rubiovalera M^{10, 11} ; Palacin M^{2, 4, 12} ; Castellanos J⁵ ; Lores L⁷ ; Zorzano A^{2, 3, 4} Show Affiliations
Source: Autophagy Published:2024

Abstract

Sarcopenia is a major contributor to disability in older adults, and thus, it is key to elucidate the mechanisms underlying its development. Increasing evidence suggests that impaired macroautophagy/autophagy contributes to the development of sarcopenia. However, the mechanisms leading to reduced autophagy during aging remain largely unexplored, and whether autophagy activation protects from sarcopenia has not been fully addressed. Here we show that the autophagy regulator TP53INP2/TRP53INP2 is decreased during aging in mouse and human skeletal muscle. Importantly, chronic activation of autophagy by muscle-specific overexpression of TRP53INP2 prevents sarcopenia and the decline of muscle function in mice. Acute re-expression of TRP53INP2 in aged mice also improves muscle atrophy, enhances mitophagy, and reduces ROS production. In humans, high levels of TP53INP2 in muscle are associated with increased muscle strength and healthy aging. Our findings highlight the relevance of an active muscle autophagy in the maintenance of muscle mass and prevention of sarcopenia. Abbreviation: ATG7: autophagy related 7; BMI: body mass index; EIF4EBP1: eukaryotic translation initiation factor 4E binding protein 1; MAP1LC3/LC3: microtubule associated protein 1 light chain 3; ROS: reactive oxygen species; TP53INP2: tumor protein p53 inducible nuclear protein 2; WT: wild type. © 2024 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group.